| 2025年中报 | 2024年年报 | |
|---|---|---|
| 营业收入(元) | ||
| 成品药(元) | 95,685,214.04 | 220,017,289.35 |
| 原料药及中间体(元) | 699,658,986.44 | 1,140,661,346.06 |
| 贸易产品(元) | 22,520,348.20 | 111,391,211.30 |
| 营业成本(元) | ||
| 成品药(元) | 13,366,514.09 | 33,635,889.75 |
| 原料药及中间体(元) | 295,371,449.77 | 484,197,805.11 |
| 贸易产品(元) | 18,762,810.40 | 91,986,955.19 |
| 毛利(元) | ||
| 成品药(元) | 82,318,699.95 | 186,381,399.60 |
| 原料药及中间体(元) | 404,287,536.67 | 656,463,540.95 |
| 贸易产品(元) | 3,757,537.80 | 19,404,256.11 |
| 毛利率(%) | ||
| 成品药(%) | 86.03 | 84.71 |
| 原料药及中间体(%) | 57.78 | 57.55 |
| 贸易产品(%) | 16.69 | 17.42 |
| 收入构成(%) | ||
| 成品药(%) | 11.70 | 14.95 |
| 原料药及中间体(%) | 85.55 | 77.49 |
| 贸易产品(%) | 2.75 | 7.57 |
| 毛利构成(%) | ||
| 成品药(%) | 16.79 | 21.62 |
| 原料药及中间体(%) | 82.45 | 76.13 |
| 贸易产品(%) | 0.77 | 2.25 |